N/A N=21 Real-time Attended Home-polysomnography Through Telematic Data Transmission
Obstructive Sleep Apnea
Primary: Quality of Polysomnographic Recordings — 10 percentage of recording failure
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=190 Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing
Obstructive Sleep Apnea · Central Sleep Apnea · Mixed Sleep Apnea
Primary: Agreement Between Polysomnography (PSG) and SomnaPatch in Detecting Patients Apnea-Hypopnea Index (AHI) — 87.1 percentage of device agreements
N/A N=115 Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography
Sleep Apnea
Primary: Apnea-hypopnea Indices (AHI) as Determined by Polysomnography (PSG) vs Automatic Event Detection (AED ) Algorithm — 5.6; 5.8; 2.4; 3.2 events per hour — p=0.007
N/A N=11 Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients
Sleep Apnea, Obstructive
Primary: Greater Than or Equal to 6 Hours of Sleep Data — 1 Participants
N/A N=45 WatchPAT Device Validation Study Compared to Polysomnography
Sleep Apnea Syndromes · Sleep Disorder · Sleep
Primary: Peripheral Arterial Tone Apnea-hypopnea Index (PAHI) — 13.3 events per hour
N/A N=45 Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography
Sleep Apnea Central · Cheyne-Stokes Respiration · Obstructive Sleep Apnea
Primary: Number of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous Polysomnography — 16.5; 18.1; 11.4; 11.5…
Phase 3 N=10 PMP-300E (Smart Watch): Portable Monitoring Device Study
Obstructive Sleep Apnea
Primary: AHI — 19.2; 19.3 events/hour — p=>0.05
N/A N=124 Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure
Preeclampsia · Hypertension
Primary: Nocturnal Blood Pressure — 128.2; 124.7; 70.6; 68.8 mmHg — p=0.45
Phase 3 N=309 Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers
Obstructive Sleep Apnea Syndrome
Primary: Percentage of Oxygen Saturation in the Brain During Sleep — 53.462; 53.13 Percentage of brain oxygen saturation
N/A N=106 A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test
Sleep Apnea
Primary: Pearson Correlation Between the AHI — 0.909 Correlation coefficient
N/A N=102 Comparison of 2 Different Hook-up Protocols to Perform Home-based Polysomnography
Sleep Disordered-breathing
Primary: Failure Rate of Sleep Study — 6; 6 percentage of participants
N/A N=53 TatchSleep as a Tool to Aid in Sleep Apnea Analysis
Sleep Apnea · Sleep Disorder
Primary: Correlation Between Polysomnography (PSG) and Tatch Apnea/Hypopnea Index (AHI) — 0.95 correlation coefficient (r)
N/A N=92 A Multi-Center Study to Assess the Performance of Saturation Patterns.
Sleep-Disordered Breathing · Obstructive Sleep Apnea · Sleep Apnea
Primary: Sensitivity and Specificity Data of the Saturation Pattern Detection (SPD) Feature as a Predictor of Repetitive Reductions in Airflow (RRiA). — 0.820; 0.897 Ratio
N/A N=38 Examining the Association Between Pre-existing Sleep Disturbance and Postoperative Delirium
Delirium
Primary: Association Between Sleep and POD — 278.5; 313.5 Minutes
N/A N=130 ApneaLink Air Home Sleep Testing (HST) Device Validation Study
Sleep-disordered Breathing
Primary: Diagnostic Sensitivity of Apnealink (AL) Compared With Polysomnography (PSG) — 91.5 percent of agreement between AL and PSG
N/A N=7 The Use of Psychomotor Vigilance Testing in the Assessment of Pediatric Obstructive Sleep Apnea
Pediatric Obstructive Sleep Apnea
Primary: Number of Participants Who Achieved Criteria of Obstructive Sleep Apnea in the PVT Assessment — 5; 2 Participants
N/A N=156 Continuous Positive Airway Pressure (PAP) Titration and Treatment Versus Auto-adjusting PAP Treatment for Sleep Apnea
Obstructive Sleep Apnea
Primary: Positive Airway Pressure Adherence (Nightly Use of Treatment) — 3.99; 4.45 hours — p== 0.27
N/A N=18 Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea
Sleep Apnea · Sleep Disordered Breathing
Primary: Salivary Cortisol Level
N/A N=200 Clinical Validation of New Commercial Sleep Monitoring Devices
Sleep Apnea
Primary: Total Sleep Time as Measured by Fitbit Charge2 or Microsoft Band2. — 437.0; 394.9 minutes — p=<0.001
Phase 2 N=326 Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)
Primary Insomnia
Primary: Sleep Efficiency (SE) on Night 1 and After 4 Weeks of Treatment — 74.8; 83.3; 84.8; 85.6 percentage of time in bed spent sleeping — p=<0.001
N/A N=47 Estimating Apnea Phenotypes From Polysomnography: Oxygen
Sleep Apnea
Primary: Apnea-hypopnea Index — 40.5; 57.9; 48.5; 74.3 events/hour — p=0.4
N/A N=306 DreamKit Diagnostic Validation
Sleep Apnea, Obstructive · Sleep Apnea, Central
Primary: Intraclass Correlation Coefficient (ICC) of the Apnea Hypopnea Index — 0.964 intraclass correlation coefficient (ICC)
N/A N=36 Evaluation of an Algorithm to Detect Sleep and Wake in Continuous Positive Airway Pressure (CPAP)
Sleep Apnea, Obstructive
Primary: Sleep/Wake Algorithm — 62 accuracy (%)
N/A N=32 Auto Continuous Positive Airway Pressure (CPAP) Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)
Sleep Apnea, Obstructive
Primary: Apnea Hypopnea Index (AHI) — 2.4 events per hour
Phase 2 N=137 Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients
Primary Insomnia
Primary: Latency to Persistent Sleep — -22.7; -39.1; -37.5 minutes
N/A N=45 A High Density EEG Comparison of Sleep Patterns in Insomnia
Primary Insomnia
Primary: EEG Power During Sleep — 1.40; 1.17 μV^2/Hz — p=0.2791
Phase 3 N=85 Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance
Restless Legs Syndrome
Primary: Wake After Sleep Onset (WASO) — 51.50; 78.42; 78.60 minutes — p=<0.0001
N/A N=29 Bipap Automatic Servo Ventilation (autoSV) Advanced in Central Apnea Patients
Cheyne-Stokes Respiration · Sleep Apnea, Central
Primary: Apnea/Hypopnea Index (AHI) — 55; 37; 12 Apnea-Hypopnea events per hour
Phase 3 N=1,105 Apnea Positive Pressure Long-Term Efficacy Study
Lung Diseases · Sleep Apnea Syndromes · Sleep
Primary: Effect of CPAP on Neurocognitive Function: E/F Function- SWMT-OMD — 0.035; -0.074; 0.072; 0.018 score on a scale — p=0.0074
Phase 3 N=136 Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance
Restless Legs Syndrome · Restless Legs Syndrome (RLS)
Primary: Adjusted Mean Change From Baseline in Wake Time During Sleep (WTDS) at Week 4/10 Measured by Polysomnography (PSG) (Sleep Study) Using Last Observation Carried Forward…